China Pharmaceutical Intermediates Industry Market Analysis

Pharmaceutical intermediates are a kind of fine chemical products in the production process from pharmaceutical chemical raw materials to API or drugs, and the synthesis of chemical drugs depends on high quality pharmaceutical intermediates.

From 2017 to 2019, China's pharmaceutical intermediates market has been showing a negative growth trend, but due to the impact of the outbreak of the epidemic in 2020, the global pharmaceutical market is climbing rapidly, and it is expected that China's pharmaceutical intermediates market size body is expected to grow to 231 billion yuan in 2022. MONADChamical shows you.

Industry access

Drug safety is a matter of national security and livelihood, the state has formulated a series of laws and regulations in the access, production, operation and sales of the pharmaceutical industry to strengthen the regulation and supervision of the pharmaceutical industry.

According to the "Supervision and Administration of Pharmaceutical Production", the opening of a pharmaceutical production enterprise must be approved by the regulatory authority of the enterprise's location and issued a drug production license, otherwise it is not allowed to produce drugs.

In addition, the pharmaceutical industry is highly globalized, especially the chemical API manufacturing industry has formed a stable division of labor system in global collaboration, and now China has become one of the largest producers of chemical APIs in the world. If domestic enterprises want to enter the market in Europe and the United States, they need to meet the local regulatory requirements. The regulatory requirements of each region has raised the threshold of entry into the industry, especially for new entrants, whether to meet the regulatory requirements of domestic or foreign, it takes a long time.

Technology

Pharmaceutical manufacturing industry is a technology-intensive industry, research and development capabilities are the core competitive ability of pharmaceutical manufacturing enterprises.

Pharmaceutical manufacturing industry has cross-disciplinary applications, multi-technology integration, rapid technological updates and other characteristics, not only is the key to the survival and development of pharmaceutical manufacturing enterprises, but also to promote the continuous progress and development of the entire pharmaceutical manufacturing industry driving force. Chemical API companies must have strong technical strength and rich experience reserves if they want to maintain their advantages and achieve sustainable development in the global market competition.

Environmental barriers

As API and pharmaceutical intermediates manufacturing is a heavy pollution industry, so the environmental protection requirements are higher than the general industry. As the public's awareness of environmental protection increases and the country's environmental protection requirements continue to improve, the design of production processes and the treatment and discharge of pollutants will continue to increase significantly. Therefore, companies that do not have the advantage of environmental technology will gradually be eliminated, and the strength of new entrants will also be rejected by the environmental barriers.

Wuhan Monad Pharmaceutical Technology Co., Ltd. is a high-tech company integrating R&D, production and sales, with main products involving APIs, pharmaceutical intermediates and natural extracts. Over the years, with the international leading product development technology and advanced multinational enterprise management mode, we have been maintaining strategic partnership with the world's top 500 pharmaceutical and biotechnology companies. If you have any questions, you can contact our experts and we will answer all kinds of concerns for you.